Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for banking industry professionals · Tuesday, September 27, 2022 · 593,040,199 Articles · 3+ Million Readers

Kaleidoscope Innovation Integrates Regulatory Mark to Offer Global Regulatory Service

CINCINNATI, Aug. 17, 2022 /PRNewswire/ -- Kaleidoscope Innovation announced today that the regulatory, quality and clinical affairs consulting group, Regulatory Mark, is now part of the team at Kaleidoscope Innovation, an Infosys company specializing in the full spectrum of product design and development.

Kaleidoscope to triple the volume of packages they will submit for US and global EU clearance during the next two years.

Led by regulatory industry veterans Alison Sathe and Colleen Murphy, the Regulatory Mark team will work closely with Elliott Fegelman, MD, Kaleidoscope's Chief Medical Officer and VP of Medical Affairs, to expand and streamline the design consultancy's regulatory strategy, licensing and support services. This includes leading FDA and EU MDR regulatory submissions for global regulatory licensing and ongoing compliance.

According to Fegelman, this formal partnership was a natural progression in an already strong working relationship between Kaleidoscope and Regulatory Mark. Since 2016, Kaleidoscope Innovation and Regulatory Mark have completed approximately 40 joint regulatory submission projects for medical device clients—all of which received regulatory clearance.

As the regulatory affairs market grows exponentially, Kaleidoscope projects they will triple the volume of packages they will submit for US and global EU clearance during the next two years.

"This merger allows us to offer a true total product lifecycle (TPLC) approach and integrate seamlessly with Kaleidoscope's existing best-in-class processes," Sathe and Murphy explained. "From regulatory strategy and planning at the concept stage through design and development and into post-market we can share insights to ensure efficient regulatory submissions and ongoing compliance."

"The joining of these leadership teams and capabilities will allow us to offer our medical device clients—and ultimately the patients they serve—even more comprehensive and efficient services," Fegelman explained. "We're augmenting what's already there—now with in-house, end-to-end capabilities."

Learn more about Kaleidoscope Innovation and Regulatory Mark.

ABOUT KALEIDOSCOPE INNOVATION

Kaleidoscope Innovation, an Infosys company, is a full-service product development firm innovating across medical, consumer and industrial markets. For over 30 years clients have partnered with Kaleidoscope to improve the human experience. Offering both consultancy-style and onsite services, they provide a full breadth of disciplines to meet their partners where needed, including: Insights & Human Factors, Medical Affairs, Industrial Design & User Experience, Engineering, Visualization and Software Development.

MEDIA CONTACT

Elliott Fegelman
Chief Medical Officer and VP of Medical Affairs
(800) 930-5793
info@kascope.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/kaleidoscope-innovation-integrates-regulatory-mark-to-offer-global-regulatory-service-301607197.html

SOURCE Kaleidoscope Innovation

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release